PINK1 and Parkinson disease: To the best of our knowledge, this is a full‐scale study of such a topic in the PD biomarker fields, and we detail baseline plasma MAP (e.g., PINK1, Parkin, and PGAM5) levels of PD and PDs compared with healthy controls.